Q4 2024 Lifeward Ltd Earnings Call Transcript
Key Points
- Lifeward Ltd (LFWD) achieved record revenue of $7.5 million in Q4 2024, marking the highest quarterly revenue in the company's history.
- The company reported an 85% increase in full-year revenue for 2024, reaching $25.7 million, demonstrating significant business scaling.
- Lifeward Ltd (LFWD) has established a Sustainable Growth Plan aimed at reducing costs and improving operating efficiency.
- The company has expanded its distribution agreement with MYOLYN, allowing for greater market penetration, particularly in the home market.
- Lifeward Ltd (LFWD) has secured a meaningful contract with BARMER in Germany, setting a standard for providing exoskeletons.
- The ReWalk sales were below expectations due to delays and attrition in Medicare cases, impacting revenue predictability.
- GAAP gross margin decreased to 24.4% in Q4 2024 from 35.5% in Q4 2023, primarily due to restructuring charges.
- The company recorded a $9.8 million impairment charge on intangible assets, affecting GAAP operating expenses.
- Lifeward Ltd (LFWD) received a going concern qualification from auditors, reflecting concerns about the adequacy of its balance sheet.
- The company experienced patient attrition and deferrals in the ReWalk product line, affecting sales cycles and revenue.
Good day and welcome to the life earning fourth quarter 2024 earnings conference call. (Operator Instructions) Please note today's event is being recorded.
And now I'd like to turn the conference over to Mike Lawless, Chief Financial Officer.
Thank you, Rocco. Good morning and welcome to Lifeward fourth quarter 2024 earnings call. I'm Mike Lawless, Lifeward Chief Financial Officer, and with me on today's call is Larry Jasinski, our Chief Executive Officer, and Almog Adar, our Vice President of Finance.
Early this morning, Lifeward issued a press release detailing financial results for the three months and full year ended December 31, 2024, which, along with this call, discussed certain non-GAAP information. I would ask you to review the full text of our forward-looking statements from this morning's press release. We anticipate making projections during this call, and actual results could differ materially due to several factors, including those outlined in our latest filings with the SEC.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
